BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35404869)

  • 1. Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients.
    Martini S; Tandoi F; Romagnoli R; Rizzetto M
    Transplantation; 2022 Oct; 106(10):1935-1939. PubMed ID: 35404869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis Delta Infection: A Clinical Review.
    Pearlman B
    Semin Liver Dis; 2023 Aug; 43(3):293-304. PubMed ID: 37473778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis delta and HIV infection.
    Soriano V; de Mendoza C; Treviño A; Ramos-Rincón JM; Moreno-Torres V; Corral O; Barreiro P
    Liver Int; 2023 Aug; 43 Suppl 1():108-115. PubMed ID: 35748639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
    Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
    J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
    Goyal A; Murray JM
    Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease.
    Serin A; Tokat Y
    Transplant Proc; 2019 Sep; 51(7):2457-2460. PubMed ID: 31405744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in delta virus infection.
    Roche B; Samuel D
    Semin Liver Dis; 2012 Aug; 32(3):245-55. PubMed ID: 22932973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Hepatitis B and D Virus Infection in a Liver Transplant Recipient.
    Miyaaki H; Tamada Y; Hayashi K; Taura N; Miuma S; Shibata H; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
    Transplant Proc; 2017; 49(1):175-177. PubMed ID: 28104130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short article: Hepatitis delta in patients with resolved hepatitis B virus infection.
    Aguilera A; Rodríguez-Calviño J; de Mendoza C; Soriano V
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1063-1065. PubMed ID: 29927770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
    Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
    Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis delta virus: From infection to new therapeutic strategies.
    Niro GA; Ferro A; Cicerchia F; Brascugli I; Durazzo M
    World J Gastroenterol; 2021 Jun; 27(24):3530-3542. PubMed ID: 34239267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of hepatitis B and delta coinfection in Israel.
    Shirazi R; Ram D; Rakovsky A; Bucris E; Gozlan Y; Lustig Y; Shaked-Mishan P; Picard O; Shemer-Avni Y; Ben-Zvi H; Halutz O; Lurie Y; Veizman E; Carlebach M; Braun M; Naftaly MC; Shlomai A; Safadi R; Mendelson E; Sklan EH; Ben-Ari Z; Mor O
    BMC Infect Dis; 2018 Feb; 18(1):97. PubMed ID: 29486716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant.
    Tandoi F; Nada E; Pittaluga F; Fop F; Lupo F; Romagnoli R; Salizzoni M
    Transplant Proc; 2014 Sep; 46(7):2308-11. PubMed ID: 25242775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient.
    Bahde R; Hölzen JP; Wolters HH; Schmidt HH; Bock CT; Lügering A; Spieker T; Senninger N; Brockmann JG
    Ann Hepatol; 2011; 10(3):355-60. PubMed ID: 21677340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adventure of delta.
    Rizzetto M
    Liver Int; 2016 Jan; 36 Suppl 1():135-40. PubMed ID: 26725911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
    Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
    Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.